| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acquired resistance to cancer immunotherapy
|
Draghi, Arianna
|
|
2018
|
41 |
1 |
p. 31-40
|
artikel
|
| 2 |
Anti-cancer immunotherapy: breakthroughs and future strategies
|
Andersen, Mads Hald
|
|
2018
|
41 |
1 |
p. 1-3
|
artikel
|
| 3 |
Cancer immune therapy for lymphoid malignancies: recent advances
|
Klausen, Uffe
|
|
2018
|
41 |
1 |
p. 111-124
|
artikel
|
| 4 |
Cancer immune therapy for myeloid malignancies: present and future
|
Holmström, Morten Orebo
|
|
2018
|
41 |
1 |
p. 97-109
|
artikel
|
| 5 |
Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer
|
Schmidt, Emmett V.
|
|
2018
|
41 |
1 |
p. 21-30
|
artikel
|
| 6 |
Does patient age influence anti-cancer immunity?
|
Pawelec, Graham
|
|
2018
|
41 |
1 |
p. 125-131
|
artikel
|
| 7 |
Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond
|
Muller, Alexander J.
|
|
2018
|
41 |
1 |
p. 41-48
|
artikel
|
| 8 |
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
|
Saetersmoen, Michelle L.
|
|
2018
|
41 |
1 |
p. 59-68
|
artikel
|
| 9 |
Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?
|
Hasselbalch, Hans Carl
|
|
2018
|
41 |
1 |
p. 5-19
|
artikel
|
| 10 |
Principles of adoptive T cell therapy in cancer
|
Met, Özcan
|
|
2018
|
41 |
1 |
p. 49-58
|
artikel
|
| 11 |
Therapeutic cancer vaccine: building the future from lessons of the past
|
Tran, T.
|
|
2018
|
41 |
1 |
p. 69-85
|
artikel
|
| 12 |
The T-win® technology: immune-modulating vaccines
|
Andersen, Mads Hald
|
|
2018
|
41 |
1 |
p. 87-95
|
artikel
|
Tijdschrift beschrijving